« neurologisch | neuro Nachlese

Status epilepticus – Herausforderungen in Diagnostik und Therapie

12. November 2020
Kongress-Highlights

Melden Sie sich bitte kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

AutorIn: Dr. Alexandra Rohracher

Universitätsklinik für Neurologie Salzburg, Paracelsus Medizinische Privatuniversität Salzburg

Literatur:
  1. Neligan A, Noyce AJ, Gosavi TD et al., Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time: A Systematic Review and Meta-analysis. JAMA Neurol 2019; 76:897–905
  2. Leitinger M, Trinka E, Giovannini G et al., Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes. Epilepsia 2019; 60:53–62
  3. Trinka E, Höfler J, Zerbs A, Causes of status epilepticus. Epilepsia 2012; 53 Suppl 4:127–38
  4. Neligan A, Shorvon SD, Frequency and prognosis of convulsive status epilepticus of different causes: A systematic review. United States; 2010 Aug
  5. Chen JWY, Wasterlain CG, Status epilepticus: Pathophysiology and management in adults. Lancet Neurol 2006; 5:246–56
  6. Trinka E, Kälviäinen R, 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017; 44:65–73
  7. Shorvon S, Ferlisi M, The treatment of super-refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol. Brain 2011; 134:2802–18
  8. Trinka E, Cock H, Hesdorffer D et al., A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56:1515–23
  9. Leitinger M, Höller Y, Kalss G et al., Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care 2015; 22:273–82
  10. Ferlisi M, Hocker S, Trinka E, Shorvon S, Singh G, Kalviainen R, Kramer U, Godoy D, Newton C, O‘Brien T, Cook M, Rossetti A, Groppa S, Kumlien E, Ercegovac M, Yasiry Z, Guecht A, Wu T, Nabbout, Reinikainen M, Etiologies and characteristics of refractory status epilepticus cases in different areas of the world: Results from a global audit. Epilepsia 2018; S2:100–107
  11. Leitinger M, Trinka E, Gardella E et al., Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: A retrospective study. Lancet Neurol 2016; 15:1054–62
  12. Kellinghaus C, Rossetti AO, Trinka E et al., Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE). Ann Neurol 2019; 85:421–32
  13. Trinka E, Höfler J, Leitinger M et al., Pharmacotherapy for Status Epilepticus. Drugs 2015; 75:1499–521
  14. Sutter R, Marsch S, Fuhr P et al., Anesthetic drugs in status epilepticus: Risk or rescue? A 6-year cohort study. Neurology 2014; 82:656–64
  15. Alvarez V, Lee JW, Westover MB et al., Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study. Neurology 2016; 87:1650–9
  16. Hirsch LJ, Gaspard N, van Baalen A et al., Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018; 59:739–44
  17. Gofton TE, Gaspard N, Hocker SE, et al., New onset refractory status epilepticus research: What is on the horizon? Neurology 2019; 92:802–10
  18. Gaspard N, Foreman BP, Alvarez V et al., New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology 2015; 85:1604–13
Ursprünglich erschienen:
neuro Nachlese
Herausgeber: Österreichische Gesellschaft für Neurologie, Univ.-Prof. Dr. Thomas Berger, MSc, Präsident der ÖGN
Publikationsdatum: 2020-11-12
Zur Ausgabe »
« neurologisch | neuro Nachlese